Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Employment agrmnt
Appointed director
Consulting agrmnt
Director departure
|
|
THERALINK TECHNOLOGIES, INC. (OBMP)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/14/2019 |
4/A
| Hoverman Daniel S. (Director) has filed a Form 4 on OncBioMune Pharmaceuticals, Inc|
Txns:
| Granted 3,000,000 options to buy
@ $0.0135, valued at
$40.5k
Granted 350,000 options to buy
@ $0.27, valued at
$94.5k
|
|
| 03/14/2019 |
4/A
| RICE CHARLES L JR (Director) has filed a Form 4 on OncBioMune Pharmaceuticals, Inc|
Txns:
| Granted 3,000,000 options to buy
@ $0.0135, valued at
$40.5k
Granted 350,000 options to buy
@ $0.27, valued at
$94.5k
|
|
| 03/14/2019 |
4/A
| KUCHARCHUK ANDREW ALBERT (CFO) has filed a Form 4 on OncBioMune Pharmaceuticals, Inc|
Txns:
| Granted 3,000,000 options to buy
@ $0.0135, valued at
$40.5k
Granted 2,000,000 options to buy
@ $0.25, valued at
$500k
|
|
| 03/14/2019 |
4/A
| HEAD JONATHAN FREDERICK (CEO) has filed a Form 4 on OncBioMune Pharmaceuticals, Inc|
Txns:
| Granted 500,000 shares
@ $0 |
|
| 03/14/2019 |
4/A
| HEAD JONATHAN FREDERICK (CEO) has filed a Form 4 on OncBioMune Pharmaceuticals, Inc|
Txns:
| Granted 3,000,000 options to buy
@ $0.0135, valued at
$40.5k
Granted 2,000,000 options to buy
@ $0.25, valued at
$500k
|
|
| 04/20/2017 |
4/A
| HEAD JONATHAN FREDERICK (Chief Excecuite Officer) has filed a Form 4 on OncBioMune Pharmaceuticals, Inc |
| 04/20/2015 |
4/A
| DIETRICH Constantin (CEO) has filed a Form 4 on QUINT MEDIA INC. |
|
|